New study targets lethal fungal infection

July 24, 2017, University of Queensland
UQ study targets lethal fungal infection
Crystal structure at 2.1 Å resolution of the target enzyme, ADS lyase. The inset shows detailed structure of the active site. Credit: University of Queensland

The development of new drugs to fight a common fungal pathogen which kills half a million people globally each year is a step closer thanks to a University of Queensland-led study.

UQ PhD student Jessica Chitty of the Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, said the study targeted the fungus Cryptococcus neoformans, which had shown signs of becoming resistant to current medications.

"This is a fungus that can be found around the world and when inhaled, its microscopic cells can cause in people with a weakened immune system," she said.

"Infections are particularly prevalent in people with advanced AIDS but can also occur in transplant recipients and those on .

"Recently two rare cases of Cryptococcus neoformans infections occurred in Australia in immunocompetent people."

Co-author Associate Professor James Fraser said drugs used to treat the disease have been around for a few decades and consequently resistance had become a problem in the treatment of infection.

"The current antifungals we have are ineffective and require close monitoring of the patients," he said.

"Our lab is looking for new drug targets. Fungi are much more closely related to humans, so a drug that kills fungi is probably just as good at killing humans.

"Instead we are examining subtle differences in enzymes that are shared between fungi and humans."

Researchers are targeting an enzyme in the fungus that has a dual role in a pathway necessary for human and to make DNA, and consequently to grow.

"If we can stop the enzyme, we can stop both jobs it performs at once, and therefore stop new cells being made," Ms Chitty said.

"But because it is an enzyme shared by both the disease-causing fungus, and a human host, we need to look for differences between the two so that a new only stops the fungal from functioning."

Explore further: Scientists discover bird blood cell which destroys fatal fungal infection

More information: Jessica L. Chitty et al. Cryptococcus neoformansADS lyase is an enzyme essential for virulence whose crystal structure reveals features exploitable in antifungal drug design, Journal of Biological Chemistry (2017). DOI: 10.1074/jbc.M117.787994

Related Stories

Scientists discover bird blood cell which destroys fatal fungal infection

February 17, 2016
Scientists have discovered that a specialised white blood cell found in birds can destroy a potentially fatal fungal infection which affects more than one million people every year.

Angina drug could inform a new strategy to fight cryptococcosis

June 7, 2016
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.

Recommended for you

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Antibiotic prescribing influenced by team dynamics within hospitals

November 15, 2018
Antibiotic prescribing by doctors is influenced by team dynamics and cultures within hospitals.

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

Maternally acquired Zika immunity can increase dengue disease severity in mouse pups

November 14, 2018
To say that the immune system is complex is an understatement: an immune response protective in one context can turn deadly over time, as evidenced by numerous epidemiological studies on dengue infection, spanning multiple ...

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.